| 585 |
584: Inhibition, sodium channel |
585: Decreased, Sodium conductance 1 |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 590 |
584: Inhibition, sodium channel |
444: Increased, Atrioventricular block and bradycardia |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1242 |
584: Inhibition, sodium channel |
1176: Decreased, sodium conductance 2 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3414 |
584: Inhibition, sodium channel |
698: Altered, Action Potential |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 867 |
845: Inhibition, UROD |
844: Oxidation, Uroporphyrinogen |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1070 |
845: Inhibition, UROD |
846: Accumulation, Highly carboxylated porphyrins |
Nov 29, 2016 |
May 30, 2018 |
1 AOP
|
| 335 |
305: Inhibition, VegfR2 |
28: Reduction, Angiogenesis |
Nov 29, 2016 |
Jul 20, 2022 |
1 AOP
|
| 1382 |
1294: Inhibition, Wnt pathway |
1295: Defect of Embryogenesis |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 3331 |
2255: Activation of the innate immune response |
272: Activation/Proliferation, T-cells |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3341 |
2255: Activation of the innate immune response |
2260: Activation of gluten-reactive CD4+ T cells |
Sep 13, 2024 |
Jun 17, 2025 |
1 AOP
|
| 2702 |
2037: Activation, IP3R |
389: Increased, Intracellular Calcium overload |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 3037 |
2037: Activation, IP3R |
1350: Increased, glutamate |
Sep 8, 2023 |
Sep 8, 2023 |
1 AOP
|
| 329 |
298: Insufficiency, Vascular |
183: Abnormal, Morphogenesis |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1036 |
298: Insufficiency, Vascular |
1001: Increased, Developmental Defects |
Nov 29, 2016 |
Jan 18, 2022 |
1 AOP
|
| 1836 |
1584: Interaction of α-diketones with arginine residues |
1585: Proteasomal dysfunction |
Jan 30, 2019 |
Jan 30, 2019 |
1 AOP
|
| 1017 |
979: Interference, nuclear localization of NFAT |
981: Reduction, NFAT/AP-1 complex formation |
Nov 29, 2016 |
Jul 2, 2021 |
1 AOP
|
| 2497 |
1901: IFN-I response, antagonized |
1847: SARS-CoV-2 production |
Oct 24, 2021 |
Dec 14, 2023 |
5 AOPs
|
| 1118 |
1074: interruption, Ovulation |
1076: Increased, circulating estrogen levels |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2490 |
1931: Disruption of the intestinal barrier |
1497: Recruitment of inflammatory cells |
Oct 19, 2021 |
Oct 19, 2021 |
None
|
| 2494 |
1931: Disruption of the intestinal barrier |
1932: GI disorders |
Oct 19, 2021 |
Oct 19, 2021 |
None
|
| 2495 |
1931: Disruption of the intestinal barrier |
1868: Hyperinflammation |
Oct 19, 2021 |
Feb 8, 2023 |
None
|
| 3335 |
1931: Disruption of the intestinal barrier |
2257: Celiac disease |
Aug 13, 2024 |
Feb 27, 2025 |
1 AOP
|
| 3789 |
1931: Disruption of the intestinal barrier |
2428: PAMPs, increased |
Apr 27, 2026 |
Apr 27, 2026 |
1 AOP
|
| 3564 |
2339: Intracellular copper, increased |
1632: Increase in RONS |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3571 |
2339: Intracellular copper, increased |
2340: Oligomerisation of DLAT, increased |
Aug 13, 2025 |
Aug 13, 2025 |
1 AOP
|